Increase in Metastatic Prostate Cancer by 72 Percent

In a study published in Prostate Cancer and Prostatic Diseases, suggests efforts to limit the use of the prostate-specific antigen (PSA) test may be partially responsible for a rise in incidences of the most aggressive form of the disease. Read article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.